On December 11, 2024, SMART and Beijing Tiantan Hospital forged a strategic partnership during a formal signing ceremony at SMART's Weiguang Campus. The agreement was signed by Nieng Yan, Founding President of SMART, and Yongjun Wang, President of Beijing Tiantan Hospital. The event was also attended by Huan Tu, Vice President of SMART and Deputy Director of Shenzhen Bay Laboratory; Xinhao Zhang, Assistant to the President of SMART and Deputy Director of Shenzhen Bay Laboratory; Wenbiao Gan, Director of the SZBL Institute of Neurological and Psychiatric Research; Shuya Li, Director of the Clinical Trial Center at Beijing Tiantan Hospital; and Beibei Xu, Director of the National Neurological Diseases Medical Center Office.

During the meeting, Yongjun Wang highlighted the remarkable journey of Beijing Tiantan Hospital, including its groundbreaking achievements in scientific research, clinical trials, and collaborations with other institutions. He expressed confidence for the partnership with SMART, emphasizing the potential to harness SMART's cutting-edge platform to drive transformative advancements in foundational and clinical research. Together, the two institutions aspire to establish benchmark projects in clinical research and catalyze innovation in Guangming, Shenzhen.

Leading researchers from Shenzhen Bay Laboratory delivered compelling presentations, showcasing significant breakthroughs across various disciplines. Topics spanned from translational innovation to advancements in neurological disease research. Engaging and productive dialogues between researchers and clinicians enriched the collaboration, creating an atmosphere of shared vision and dynamic innovation.

This milestone agreement ushers in an exciting new chapter of collaboration between SMART and Beijing Tiantan Hospital in clinical neuroscience. The partnership promises to deliver transformative societal benefits by addressing pressing challenges in the diagnosis and clinical treatment of complex diseases.